Trials / Terminated
TerminatedNCT05845502
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Shantou University Medical College · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ003 in the treatment of advanced hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SZ003 CAR-NK | Drug: SZ003 CAR-NK In the escalation study, the minimum initial dose was 5.0×10\^6 cells, then increased to 1.0×10\^8 ,2.0×10\^8 and5.0×10\^8 cells. The infusion is given every 2 weeks. |
Timeline
- Start date
- 2021-07-26
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2023-05-06
- Last updated
- 2025-01-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05845502. Inclusion in this directory is not an endorsement.